Javascript must be enabled to continue!
Profiling Coagulation for Preeclampsia and Eclampsia
View through CrossRef
Study of Coagulation profile in preeclampsia and eclampsia comprised of 258 cases which were categorized as preeclampsia, eclampsia and control group with 86 cases in each group. A total number of 258 patients were studied which were categorized as the control group, preeclampsia group and eclampsia group with 86 cases in each. Preeclampsia was further classified as mild preeclampsia (48/86) and severe preeclampsia (38/86). Among all patients, thrombocytopenia was found in 61% of patients. All patients in the control group had platelet counts within the normal range. The method used in the present study is an analytical case-control study, carried out in the Department of Pathology in our institute. Our study includes cases of preeclampsia and eclampsia coming to the Department of Obstetrics and Gynaecology during the period of two years from May 2015 to April 2017. Newly diagnosed Preeclampsia and eclampsia patients in the third trimester of age 18 to 30 years. From this study, it can be concluded that coagulation profile can help to assess the severity of preeclampsia and eclampsia and thus can help to reduce complications if treated early. Thus as inconclusive of this study of coagulation profile has significant value and impact on management and outcome of cases of preeclampsia and eclampsia.
GP Innovations Pvt. Ltd.
Title: Profiling Coagulation for Preeclampsia and Eclampsia
Description:
Study of Coagulation profile in preeclampsia and eclampsia comprised of 258 cases which were categorized as preeclampsia, eclampsia and control group with 86 cases in each group.
A total number of 258 patients were studied which were categorized as the control group, preeclampsia group and eclampsia group with 86 cases in each.
Preeclampsia was further classified as mild preeclampsia (48/86) and severe preeclampsia (38/86).
Among all patients, thrombocytopenia was found in 61% of patients.
All patients in the control group had platelet counts within the normal range.
The method used in the present study is an analytical case-control study, carried out in the Department of Pathology in our institute.
Our study includes cases of preeclampsia and eclampsia coming to the Department of Obstetrics and Gynaecology during the period of two years from May 2015 to April 2017.
Newly diagnosed Preeclampsia and eclampsia patients in the third trimester of age 18 to 30 years.
From this study, it can be concluded that coagulation profile can help to assess the severity of preeclampsia and eclampsia and thus can help to reduce complications if treated early.
Thus as inconclusive of this study of coagulation profile has significant value and impact on management and outcome of cases of preeclampsia and eclampsia.
Related Results
Correlation of Neutrophil Lymphocyte Ration (NLR) Values with Severe Preeclampsia, HELLP Syndrome and Eclampsia
Correlation of Neutrophil Lymphocyte Ration (NLR) Values with Severe Preeclampsia, HELLP Syndrome and Eclampsia
Background:  Preeclampsia (PE) is the leading cause of maternal and fetal morbidity and mortality. The disease is characterized by hypertension (≥140/90 mmHg), proteinuria, thro...
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
<p>Preeclampsia is a hypertensive disorder of pregnancy that is diagnosed after the 20th week of gestation. It is defined by the American College of Obstetrics and Gynecology...
Maternal outcomes of severe preeclampsia and eclampsia and associated factors among women admitted at referral hospitals of amhara regional state, institutional-based cross-sectional study, North-West Ethiopia
Maternal outcomes of severe preeclampsia and eclampsia and associated factors among women admitted at referral hospitals of amhara regional state, institutional-based cross-sectional study, North-West Ethiopia
IntroductionSevere preeclampsia/eclampsia is a multi-systemic pregnancy condition that manifests after 20 weeks of gestation and is linked to a high global rate of maternal morbidi...
Alteration of Coagulation Profile in Preeclampsia And Eclampsia Patients At Tertiary Level Hospital
Alteration of Coagulation Profile in Preeclampsia And Eclampsia Patients At Tertiary Level Hospital
Background: Preeclampsia and eclampsia is associated with a risk of abnormal hemostasis that occurs most commonly secondary to thrombocytopenia. Automated analyze technique measure...
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Objetivo: Determinar las complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima - 2021 Metodología: Estudio de tipo Observacional, trasvers...
Serum catestatin level in preeclampsia
Serum catestatin level in preeclampsia
Background/Aim: Preeclampsia, a significant cause of maternal morbidity and mortality, is linked to increased cardiovascular risks. Catestatin regulates cardiovascular function whi...
Clinical presentation, maternal-fetal, and neonatal outcomes of early-onset versus late onset preeclampsia-eclampsia syndrome in a teaching hospital in a low-resource setting: A retrospective cohort study
Clinical presentation, maternal-fetal, and neonatal outcomes of early-onset versus late onset preeclampsia-eclampsia syndrome in a teaching hospital in a low-resource setting: A retrospective cohort study
Background
Pre-eclampsia-eclampsia syndrome remains the leading cause of maternal and neonatal mortality worldwide. Both from pathophysiologic and clinical stand points, early and ...
Perceptions on preeclampsia and eclampsia among older women in rural southwestern Uganda
Perceptions on preeclampsia and eclampsia among older women in rural southwestern Uganda
Abstract
Background: Eclampsia is among the leading causes of maternal mortality. It is a serious hypertensive (HT) complication of pregnancy and increases the risk of card...

